Taking care of patients requires access to recent and reliable information. In high-income settings, what once involved thumbing through the few well-worn reference books that were close at hand (and, when that failed, paying a quick visit to the stacks in the nearest medical library) has become a matter of typing a search term or two and selecting the chapter of interest in an online, point-of-care reference. The change reflects a matter greater than simply convenience: with an ever-unfolding evidence base, with ever-increasing specialization and complexity, access to the latest information is an essential part of modern medicine. Surely it is well worth paying for?
balance between imperfect knowledge and the consequences, to the extent they can be predicted, of inaction. Where the scientific evidence is not of the highest quality, both writers and readers need somehow to make the best of it.
As a professionally edited, open access medical journal with engaged academic editors from the clinical research community, PLOS Medicine seems well positioned to contribute by publishing a limited number of clinical review articles. Our colleagues at PLOS Computational Biology have already engaged in an analogous effort, albeit not one focused on patient care [3] . PLOS Medicine's scope would permit us to prioritize topics of particular urgency in settings where resources to access point-of-care information are limited. For the original journal article, the editors would maintain a strong policy on author and reviewer competing interests.
Practical issues remain to be raised and resolved, however. Perhaps the most important concern how to maintain the reliability of a living review. Editors of journals that publish original research can reasonably expect researchers to critique and verify one another's results both initially and over time, and other interested parties to comment. Facilitating these activities before changes to patient care or policy result is one of the great benefits of open access publishing in medicine. In contrast, clinicians accessing point-of-care summaries, perhaps with limited time or inclination to integrate information from multiple sources themselves, can apply the conclusions of a review to a patient's living body within seconds of reading the information. Writers and editors of such articles, therefore, must exercise commensurate vigilance in guarding against bias, competing interests, and blurring of the lines between evidence and speculation on ways of applying it. Even in the one-time publication of an article, such vigilance can be demanding; ensuring integrity in a living point-of-care reference would require ongoing processes, which would have to scale with the size of the of collection.
It may be that no currently existing model is perfectly suited to the task. A misplaced decimal point, ambiguous phrasing, or a poorly rendered symbol in a clinical reference has the potential for more immediate harm than in most other kinds of published article. Would an all-volunteer effort like Wikipedia's be adequate to ensure that the tedious but generally indispensable matter of proofreading, copyediting, and compatibility across software and media platforms will reliably occur across large numbers of summaries? Are the community standards around open re-use, which work so well for original research, optimal to ensure that competing interests excluded from a "seed" clinical review do not come to dominate subsequent versions appearing on other platforms? Will clinicians be comfortable relying on patient care information if authors are not prominently identified or may change without notice? Will authors or publishers of "seed" reviews be comfortable relinquishing control of the "sprouts?"
We believe that these issues are ripe for resolution, provided that interested journals, online information resources, potential authors, and funding agencies are motivated to focus their creative attention on them. While the PLOS Medicine Editors welcome the opportunity to participate, we feel that no single journal would serve the spirit or the effectiveness of the enterprise by seeking an exclusive role. For the production of freely available, scrupulously well written, and frequently updated clinical reviews to become a part of the future medical world-and there are global clinical benefits if they do-there will be ample work for many hands and organizations in creating, disseminating, and maintaining them.
Will communities of clinical experts engage in a sustained effort to maintain open access, point-of-care resources at the high level of quality that patient care demands? We hope so, and we encourage those who feel inspired by the potential scope and benefits of such a project to join forces in building it.
